Evidence map›Paper›PMID 37460694›Full record

ArticleNature cell biology2023

Haematopoietic stem and progenitor cell heterogeneity is inherited from the embryonic endothelium.

Joey J Ghersi, Gabriel Baldissera, Jared Hintzen, Stephanie A Luff, Siyuan Cheng, Ivan Fan Xia, Christopher M Sturgeon, Stefania Nicoli

Open access · hybridAbstract read
In one paragraph

Article in Nature cell biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Microenvironmental determinants of endothelial cell heterogeneity.Nature reviews. Molecular cell biology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. iScience · 2024
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. The evolving hematopoietic niche during development.Frontiers in molecular biosciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Joey J GhersiYale Cardiovascular Research Center, Department of Internal Medicine, Section of Cardiology, Yale University School of Medicine, New Haven, CT, USA.
Gabriel BaldisseraYale Cardiovascular Research Center, Department of Internal Medicine, Section of Cardiology, Yale University School of Medicine, New Haven, CT, USA.
Jared HintzenYale Cardiovascular Research Center, Department of Internal Medicine, Section of Cardiology, Yale University School of Medicine, New Haven, CT, USA.
Stephanie A LuffBlack Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0003-4259-3839
Siyuan ChengYale Cardiovascular Research Center, Department of Internal Medicine, Section of Cardiology, Yale University School of Medicine, New Haven, CT, USA.
Ivan Fan XiaYale Cardiovascular Research Center, Department of Internal Medicine, Section of Cardiology, Yale University School of Medicine, New Haven, CT, USA.
Christopher M SturgeonBlack Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0003-1508-4414
Stefania NicoliYale Cardiovascular Research Center, Department of Internal Medicine, Section of Cardiology, Yale University School of Medicine, New Haven, CT, USA. stefania.nicoli@yale.edu.ORCID http://orcid.org/0000-0001-7055-340X
Yale University · USIcahn School of Medicine at Mount Sinai · US

Funding

miR-223 regulates endothelial to hematopoietic transitionR01DK118728 · NIDDK · YALE UNIVERSITY · PI HIRSCHI, KAREN KEMPER, NICOLI, STEFANIA · 2020 to 2023
$2.9M
Embryonic natural killer cell development and functionR01HL151777 · NHLBI · WASHINGTON UNIVERSITY · PI PALIS, JAMES, STURGEON, CHRISTOPHER MICHAEL · 2020 to 2023
$2.3M
Mesodermal Commitment of the Definitive Hematopoietic ProgramR01HL145290 · NHLBI · WASHINGTON UNIVERSITY · PI STURGEON, CHRISTOPHER MICHAEL · 2019 to 2023
$2.1M
NHLBI NIH HHS R01 HL145290NHLBI NIH HHS R01 HL151777NIDDK NIH HHS R01 DK118728
6 · The paper itself

Abstract

Definitive haematopoietic stem and progenitor cells (HSPCs) generate erythroid, lymphoid and myeloid lineages. HSPCs are produced in the embryo via transdifferentiation of haemogenic endothelial cells in the aorta-gonad-mesonephros (AGM). HSPCs in the AGM are heterogeneous in differentiation and proliferative output, but how these intrinsic differences are acquired remains unanswered. Here we discovered that loss of microRNA (miR)-128 in zebrafish leads to an expansion of HSPCs in the AGM with different cell cycle states and a skew towards erythroid and lymphoid progenitors. Manipulating miR-128 in differentiating haemogenic endothelial cells, before their transition to HSPCs, recapitulated the lineage skewing in both zebrafish and human pluripotent stem cells. miR-128 promotes Wnt and Notch signalling in the AGM via post-transcriptional repression of the Wnt inhibitor csnk1a1 and the Notch ligand jag1b. De-repression of cskn1a1 resulted in replicative and erythroid-biased HSPCs, whereas de-repression of jag1b resulted in G2/M and lymphoid-biased HSPCs with long-term consequence on the respective blood lineages. We propose that HSPC heterogeneity arises in the AGM endothelium and is programmed in part by Wnt and Notch signalling.

Indexed as

HemangioblastsMicroRNAsAnimalsCell DifferentiationEndotheliumHematopoiesisHematopoietic Stem CellsHumansZebrafishMicroRNAs

Identifiers

PMID37460694
PMCPMC10415179
OpenAlexW4384561856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.